Cleared Traditional

K072593 - A-PLUS ARTERIAL PULSE WAVEFORM ANALYSIS...

K072593 is an FDA 510(k) clearance for A-PLUS ARTERIAL PULSE WAVEFORM ANALYSIS..., manufactured by Healthstats International Pte. , Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K072593 · Healthstats International Pte. , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
62d
Days
Class 2
Risk

K072593 is an FDA 510(k) clearance for the A-PLUS ARTERIAL PULSE WAVEFORM ANALYSIS SYSTEM AND PC SOFTWARE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Healthstats International Pte. , Ltd. (Egale, US). The FDA issued a Cleared decision on November 15, 2007 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Healthstats International Pte. , Ltd. devices

FDA 510(k) Submission Details - K072593

510(k) Number K072593 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 2007
Decision Date November 15, 2007
Days to Decision 62 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 125d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 620
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K072593.
1500 PRO
K080289 · Omron Healthcare, Inc. · Feb 2008
MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODEL WATCHBP HOME (BP3MX1-1)
K073198 · Microlife Intellectual Property GmbH · Jan 2008
AVITA BLUETOOTH BLOOD PRESSURE MONITOR, MODEL: BPM656ZB
K072137 · Avita Corporation · Dec 2007
MODIFICATION TO: DIGITAL BLOOD PRESSURE MONITOR, MODEL 1901
K071384 · Nihon Seimitsu Sokki Co., Ltd. · Oct 2007
TERUMO DIGITAL BLOOD PRESSURE MONITOR ES-H55A
K071075 · Terumo Corp. · May 2007
A&D MEDICAL UA-789 DIGITAL BLOOD PRESSURE MONITOR
K062027 · A&D Engineering, Inc. · Jan 2007